Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

YOU WONT BELIEVE: 100 - You Need To See This

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

The Independent UK

New clinical trial will test whether infections need antibiotics

At present, medics may sometimes give out antibiotics unnecessarily because it is not clear whether an infection is caused by bacteria

Wales Online

Medical device companies upselling products to surgeons in operating theatres, insider claims

A former marketing manager for medical device companies says company reps would go into operating theatres ostensibly to give surgeons technical support, but with the prime aim of selling more products.

ABC News

From analysis to the latest developments in health,
read the most diverse news in one place.

$3.5M gene therapy for hemophilia gets FDA approval

U.S. health regulators have approved the first gene therapy for hemophilia, a blood-clotting disorder with few treatment options

The Independent UK

New booster shots cut risk of symptomatic COVID-19

WASHINGTON — The new bivalent COVID-19 booster shots are up to 56% more effective at preventing symptomatic COVID-19 infection than the two original COVID-19 vaccines in adults ages 18 and up, according to new data from the Centers for Disease Control and Prevention.

Tribune News Service

US renews push for COVID boosters as data show they protect

Americans who have gotten the updated COVID-19 boosters appear better protected against symptomatic infection than those who haven't — at least for now

The Independent UK

Britain says monkeypox shot offers strong 78% protection

A single dose of the monkeypox vaccine provides 78% protection against the virus, according to data from England released on Tuesday that health officials said was the strongest evidence yet of its effectiveness.

Reuters

Read news from The Economist, FT, and more,
with one subscription

Experts are concerned Thanksgiving gatherings could accelerate a 'tripledemic'

As the holiday approaches, infectious disease specialists are bracing for the possibility that big family get-togethers and travel will propel the spread of RSV, flu and COVID-19.

WEKU

RSV: Single jab approved for virus that can cause deadly pneumonia in babies

RSV can lead to severe lung issues in very young children including bronchiolitis and pneumonia

The Independent UK

America shrugs off its twindemic

Americans are too COVID-fatigued to care.

Axios

Leeds' Tissue Regenix Group strikes agreement with German distributor

The Garforth-based business has signed a multi-year deal with the Hamburg firm

Birmingham Post

EU drugs agency concerned about rising recreational use of 'laughing gas'

The European Union's drugs agency says that recreational use of laughing gas is an increasing worry in Europe, stressing that frequent use of this gas increases the risk of poisonings, burns and nervous system damage.

Radio France Internationale

ACT contact tracing app to be 'switched off'

Canberrans have not been required to check in since May.

The Canberra Times

Narcotics board 'has no sway' over cannabis orders: Wissanu

The Office of the Narcotics Control Board (ONCB) has no authority to alter or reverse any ministerial announcements signed by Public Health Minister Anutin Charnvirakul concerning the decriminalisation of cannabis, Deputy Prime Minister Wissanu Krea-ngam said on Monday.

Bangkok Post

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

More than 6,000 tech and biotech job cuts roil Bay Area economy

Tech and biotech companies have revealed plans recently for enough job cuts to erase more than 6,000 jobs in the Bay Area, cutbacks that could weigh on the region’s economy in the weeks and months to come.

Bangkok Post

Siriraj Hospital boosts aesthetic treatment safety

Derived from the bacterium Clostridium botulinum, Botulinum toxin type A (BoNT-A) is prescribed for uncontrollable blinking, chronic migraine, overactive bladder and other medical conditions, as well as aesthetic treatments.

StockNews.com

2 Biotech Stocks to Buy in November and 1 to Sell

The biotech industry strengthened over the pandemic by drug and vaccine development initiatives to combat COVID-19. Moreover, significant government investments should bode well for this industry. Therefore, quality biotech stocks Amgen (AMGN) and Gilead Sciences (GILD) could be ideal buys in November. However, fundamentally weak stock Ginkgo Bioworks (DNA) might…

Evening Standard

David Davis admits Brexit has not delivered ‘major’ economic benefits but blames Covid

The former Brexit Secretary blames Covid for failure of leaving the EU to deliver economic benefits to the UK

Get all your
news in one place.

100's of premium titles.
One news app.

Irish Mirror

Laughing gas poisoning on the rise in Ireland

EU watchdog warning as one in four admit using nitrous oxide recreationally

Daily Record

Humza Yousaf insists NHS in Scotland will stick to 'founding principles' and won't bring in charges

Leaked minutes of a high-level meeting between NHS bosses in Scotland reveal a debate on whether to introduce a "two-tier system" as hospitals struggle to meet demand.

The National (Scotland)

Nicola Sturgeon opens 'innovative' rehab service for families impacted by drugs

FIRST Minister Nicola Sturgeon has opened an “innovative” new rehabilitation service which will allow families to stay together while a parent…

The Independent UK

Antibiotic resistance: 150 serious infections occur per day in England

Resistance occurs when bacteria, viruses, fungi and parasites mutate and no longer respond to the medicines designed to treat them.

WEKU

Hidden audits reveal millions in overcharges by Medicare Advantage plans

Taxpayers footed the bill for care that should have cost far less, according to records released under the Freedom of Information Act. The U.S. government may charge insurers $650 million as a result.

Wales Online

Common painkillers can make joint pain worse, new research shows

The study, based on over 1,000 patients, is one of the first to investigate the long term effects

Al Jazeera

Gene drug ‘only hope’ for Turkish child, but costs millions

Zolgensma may stop five-year-old Yusuf Polat’s spinal muscular atrophy from progressing, but it costs $2.1m.

1 … 99 100 101 102

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations